Schwam ZG, Burtness B, Yarbrough WG, Mehra S, Husain Z, Judson BL: National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database. Cancer Med. 2015 Oct 16; 2015 Oct 16. PMID: 26471244

Uzhachenko R, Shanker A, Yarbrough WG, Ivanova AV: Mitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunity. Oncotarget. 2015 Aug 28. PMID: 26246474

Baldassarri R, Aronberg R, Levi AW, Yarbrough WG, Kowalski D, Chhieng D: Detection and genotype of high-risk human papillomavirus in fine-needle aspirates of patients with metastatic squamous cell carcinoma is helpful in determining tumor origin. Am J Clin Pathol. 2015 May. PMID: 25873503

Farmer RW, McCall L, Civantos FJ, Myers JN, Yarbrough WG, Murphy B, O'Leary M, Zitsch R, Siegel BA: Lymphatic drainage patterns in oral squamous cell carcinoma: findings of the ACOSOG Z0360 (Alliance) study. Otolaryngol Head Neck Surg. 2015 Apr; 2015 Mar 6. PMID: 25749001

Yazlovitskaya EM, Voziyan PA, Manavalan T, Yarbrough WG, Ivanova AV: Cellular oxidative stress response mediates radiosensitivity in Fus1-deficient mice. Cell Death Dis. 2015 Feb 19; 2015 Feb 19. PMID: 25695605

Lu X, Yarbrough WG: Negative regulation of RelA phosphorylation: emerging players and their roles in cancer. Cytokine Growth Factor Rev. 2015 Feb; 2014 Oct 2. PMID: 25438737

Aronberg RM, Punekar SR, Adam SI, Judson BL, Mehra S, Yarbrough WG: Esophageal perforation caused by edible foreign bodies: a systematic review of the literature. Laryngoscope. 2015 Feb; 2014 Aug 22. PMID: 25155167

Yarbrough WG, Sewell A, Tickle E, Rhinehardt E, Harkleroad R, Bennett M, Johnson D, Wen L, Pfeiffer M, Benegas M, Morath J: A tool to determine financial impact of adverse events in health care: healthcare quality calculator. J Patient Saf. 2014 Dec. PMID: 24080720

Chen MM, Roman SA, Yarbrough WG, Burtness BA, Sosa JA, Judson BL: Trends and variations in the use of adjuvant therapy for patients with head and neck cancer. Cancer. 2014 Nov 1; 2014 Jul 15. PMID: 25042524

Parfenov M, Pedamallu CS, Gehlenborg N, Freeman SS, Danilova L, Bristow CA, Lee S, Hadjipanayis AG, Ivanova EV, Wilkerson MD, Protopopov A, Yang L, Seth S, Song X, Tang J, Ren X, Zhang J, Pantazi A, Santoso N, Xu AW, Mahadeshwar H, Wheeler DA, Haddad RI, Jung J, Ojesina AI, Issaeva N, Yarbrough WG, Hayes DN, Grandis JR, El-Naggar AK, Meyerson M, Park PJ, Chin L, Seidman JG, Hammerman PS, Kucherlapati R, Cancer Genome Atlas Network: Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A. 2014 Oct 28; 2014 Oct 13. PMID: 25313082

Kuo P, Chen MM, Decker RH, Yarbrough WG, Judson BL: Hypopharyngeal cancer incidence, treatment, and survival: temporal trends in the United States. Laryngoscope. 2014 Sep. PMID: 25295351

Moser R, Xu C, Kao M, Annis J, Lerma LA, Schaupp CM, Gurley KE, Jang IS, Biktasova A, Yarbrough WG, Margolin AA, Grandori C, Kemp CJ, Méndez E: Functional kinomics identifies candidate therapeutic targets in head and neck cancer. Clin Cancer Res. 2014 Aug 15. PMID: 25125259

Luryi AL, Yarbrough WG, Niccolai LM, Roser S, Reed SG, Nathan CA, Moore MG, Day T, Judson BL: Public awareness of head and neck cancers: a cross-sectional survey. JAMA Otolaryngol Head Neck Surg. 2014 Jul. PMID: 24902640

Yarbrough WG, Rosenthal E: Conclusions about human papillomavirus-related malignancies. Head Neck. 2014 Jun; 2013 Sep 2. PMID: 23696473

Lu X, An H, Jin R, Zou M, Guo Y, Su PF, Liu D, Shyr Y, Yarbrough WG: PPM1A is a RelA phosphatase with tumor suppressor-like activity. Oncogene. 2014 May 29; 2013 Jul 1. PMID: 23812431

Sewell A, Brown B, Biktasova A, Mills GB, Lu Y, Tyson DR, Issaeva N, Yarbrough WG: Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer. Clin Cancer Res. 2014 May 1; 2014 Mar 5. PMID: 24599934

Uzhachenko R, Ivanov SV, Yarbrough WG, Shanker A, Medzhitov R, Ivanova AV: Fus1/Tusc2 is a novel regulator of mitochondrial calcium handling, Ca2+-coupled mitochondrial processes, and Ca2+-dependent NFAT and NF-κB pathways in CD4+ T cells. Antioxid Redox Signal. 2014 Apr 1; 2014 Feb 4. PMID: 24328503

Thompson PD, Sakwe A, Koumangoye R, Yarbrough WG, Ochieng J, Marshall DR: Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B. Exp Cell Res. 2014 Feb 15; 2013 Dec 12. PMID: 24332981

Ivanov SV, Panaccione A, Brown B, Guo Y, Moskaluk CA, Wick MJ, Brown JL, Ivanova AV, Issaeva N, El-Naggar AK, Yarbrough WG: TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior. Oncogene. 2013 Aug 8; 2012 Oct 1. PMID: 23027130

Ivanov SV, Panaccione A, Nonaka D, Prasad ML, Boyd KL, Brown B, Guo Y, Sewell A, Yarbrough WG: Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas. Br J Cancer. 2013 Jul 23; 2013 Jun 25. PMID: 23799842

Yazlovitskaya EM, Uzhachenko R, Voziyan PA, Yarbrough WG, Ivanova AV: A novel radioprotective function for the mitochondrial tumor suppressor protein Fus1. Cell Death Dis. 2013 Jun 20; 2013 Jun 20. PMID: 23788044

Godoy JM, Sewell A, Johnston B, Brown BT, Lu X, Sinard RJ, Rohde S, Mannion K, Netterville JL, Yarbrough WG: Viable biobanking of primary head and neck squamous cell carcinoma. Laryngoscope. 2013 Mar; 2013 Jan 8. PMID: 23299699

Athavale SM, Rangarajan S, Dharamsi L, Wentz S, Phillips S, McRackan T, Yarbrough WG: AlloDerm and DermaMatrix implants for parotidectomy reconstruction: a histologic study in the rat model. Head Neck. 2013 Feb; 2012 Feb 2. PMID: 22302682

Slebos RJ, Jehmlich N, Brown B, Yin Z, Chung CH, Yarbrough WG, Liebler DC: Proteomic analysis of oropharyngeal carcinomas reveals novel HPV-associated biological pathways. Int J Cancer. 2013 Feb 1; 2012 Jul 20. PMID: 22733545

Husain H, Psyrri A, Markovic A, Rampias T, Pectasides E, Wang H, Slebos R, Yarbrough WG, Burtness B, Chung CH: Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma. Laryngoscope. 2012 Dec; 2012 Oct 19. PMID: 23086695

Hoshino D, Jourquin J, Emmons SW, Miller T, Goldgof M, Costello K, Tyson DR, Brown B, Lu Y, Prasad NK, Zhang B, Mills GB, Yarbrough WG, Quaranta V, Seiki M, Weaver AM: Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis. Sci Signal. 2012 Sep 11; 2012 Sep 11. PMID: 22969158

Zimmerman LJ, Li M, Yarbrough WG, Slebos RJ, Liebler DC: Global stability of plasma proteomes for mass spectrometry-based analyses. Mol Cell Proteomics. 2012 Jun; 2012 Feb 1. PMID: 22301387

Gubanova E, Brown B, Ivanov SV, Helleday T, Mills GB, Yarbrough WG, Issaeva N: Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival. Clin Cancer Res. 2012 Mar 1; 2012 Jan 13. PMID: 22247495

Gilbert J, Murphy B, Dietrich MS, Henry E, Jordan R, Counsell A, Wirth P, Yarbrough WG, Slebos RJ, Chung CH: Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer. Cancer. 2012 Feb 15; 2011 Jul 15. PMID: 21766301

Athavale SM, Phillips S, Mangus B, Datta J, Sinard RJ, Netterville JL, Burkey BB, Yarbrough WG: Complications of alloderm and dermamatrix for parotidectomy reconstruction. Head Neck. 2012 Jan; 2011 Apr 5. PMID: 21469246

Vlacich G, Diaz R, Thorpe SW, Murphy BA, Kirby W, Sinard RJ, Shakhtour B, Shyr Y, Murphy P, Netterville JL, Yarbrough WG, Cmelak AJ: Intensity-modulated radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer: toxicities and efficacy. Oncologist. 2012; 2012 May 1. PMID: 22550060

Liu D, Wang WD, Melville DB, Cha YI, Yin Z, Issaeva N, Knapik EW, Yarbrough WG: Tumor suppressor Lzap regulates cell cycle progression, doming, and zebrafish epiboly. Dev Dyn. 2011 Jun; 2011 Apr 26. PMID: 21523853

An H, Lu X, Liu D, Yarbrough WG: LZAP inhibits p38 MAPK (p38) phosphorylation and activity by facilitating p38 association with the wild-type p53 induced phosphatase 1 (WIP1). PLoS One. 2011 Jan 24; 2011 Jan 24. PMID: 21283629

Hatakeyama H, Cheng H, Wirth P, Counsell A, Marcrom SR, Wood CB, Pohlmann PR, Gilbert J, Murphy B, Yarbrough WG, Wheeler DL, Harari PM, Guo Y, Shyr Y, Slebos RJ, Chung CH: Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma. PLoS One. 2010 Sep 13; 2010 Sep 13. PMID: 20856931

Li M, Gray W, Zhang H, Chung CH, Billheimer D, Yarbrough WG, Liebler DC, Shyr Y, Slebos RJ: Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling. J Proteome Res. 2010 Aug 6. PMID: 20586475

Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson S, Gilbert J, Chung CH, Murphy BA, Yarbrough WG, Murphy PB, Shyr Y, Cmelak AJ: Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Jun 1; 2009 Jul 4. PMID: 19577867

Chung CH, Aulino J, Muldowney NJ, Hatakeyama H, Baumann J, Burkey B, Netterville J, Sinard R, Yarbrough WG, Cmelak AJ, Slebos RJ, Shyr Y, Parker J, Gilbert J, Murphy BA: Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Ann Oncol. 2010 Apr; 2009 Oct 22. PMID: 19850643

Civantos FJ, Zitsch RP, Schuller DE, Agrawal A, Smith RB, Nason R, Petruzelli G, Gourin CG, Wong RJ, Ferris RL, El Naggar A, Ridge JA, Paniello RC, Owzar K, McCall L, Chepeha DB, Yarbrough WG, Myers JN: Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol. 2010 Mar 10; 2010 Feb 8. PMID: 20142602

Murphy BA, Dietrich MS, Wells N, Dwyer K, Ridner SH, Silver HJ, Gilbert J, Chung CH, Cmelak A, Burkey B, Yarbrough WG, Sinard R, Netterville J: Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation. Head Neck. 2010 Jan. PMID: 19626644

Law JH, Whigham AS, Wirth PS, Liu D, Pham MQ, Vadivelu S, Kirkbride KC, Brown BT, Burkey BB, Sinard RJ, Netterville JL, Yarbrough WG: Human-in-mouse modeling of primary head and neck squamous cell carcinoma. Laryngoscope. 2009 Dec. PMID: 19693929

Baumann JL, Cohen S, Evjen AN, Law JH, Vadivelu S, Attia A, Schindler JS, Chung CH, Wirth PS, Meijer CJ, Snijders PJ, Yarbrough WG, Slebos RJ: Human papillomavirus in early laryngeal carcinoma. Laryngoscope. 2009 Aug. PMID: 19489068

Yang ES, Murphy BM, Chung CH, Netterville JL, Burkey BB, Gilbert J, Yarbrough WG, Sinard R, Cmelak AJ: Evolution of clinical trials in head and neck cancer. Crit Rev Oncol Hematol. 2009 Jul; 2008 Nov 7. PMID: 18996026

Clark ES, Brown B, Whigham AS, Kochaishvili A, Yarbrough WG, Weaver AM: Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Oncogene. 2009 Jan 22; 2008 Oct 20. PMID: 18931703

Mukherjee K, Cash MP, Burkey BB, Yarbrough WG, Netterville JL, Melvin WV: Antegrade and retrograde endoscopy for treatment of esophageal stricture. Am Surg. 2008 Aug. PMID: 18705567

Gilbert J, Cmelak A, Shyr Y, Netterville J, Burkey BB, Sinard RJ, Yarbrough WG, Chung CH, Aulino JM, Murphy BA: Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck. Cancer. 2008 Jul 1. PMID: 18484593

Slebos RJ, Li M, Vadivelu S, Burkey BB, Netterville JL, Sinard R, Gilbert J, Murphy B, Chung CH, Shyr Y, Yarbrough WG: Microsatellite mutations in buccal cells are associated with aging and head and neck carcinoma. Br J Cancer. 2008 Feb 12; 2008 Jan 22. PMID: 18212747

Wang J, An H, Mayo MW, Baldwin AS, Yarbrough WG: LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. Cancer Cell. 2007 Sep. PMID: 17785205

Clark ES, Whigham AS, Yarbrough WG, Weaver AM: Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 2007 May 1. PMID: 17483334

Yarbrough WG, Whigham A, Brown B, Roach M, Slebos R: Phosphoinositide kinase-3 status associated with presence or absence of human papillomavirus in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 2007. PMID: 17848307

Slebos RJ, Li M, Evjen AN, Coffa J, Shyr Y, Yarbrough WG: Mutagenic effect of cadmium on tetranucleotide repeats in human cells. Mutat Res. 2006 Dec 1; 2006 Sep 20. PMID: 16989872

Stacy DR, Ely K, Massion PP, Yarbrough WG, Hallahan DE, Sekhar KR, Freeman ML: Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Head Neck. 2006 Sep. PMID: 16637057

Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A, Levy S, Yarbrough WG, Slebos RJ, Hirsch FR: Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol. 2006 Sep 1. PMID: 16943533

Chung CH, Parker JS, Ely K, Carter J, Yi Y, Murphy BA, Ang KK, El-Naggar AK, Zanation AM, Cmelak AJ, Levy S, Slebos RJ, Yarbrough WG: Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res. 2006 Aug 15. PMID: 16912200

Yarbrough WG, Slebos RJ, Liebler D: Proteomics: clinical applications for head and neck squamous cell carcinoma. Head Neck. 2006 Jun. PMID: 16475197

Chung CH, Levy S, Yarbrough WG: Clinical applications of genomics in head and neck cancer. Head Neck. 2006 Apr. PMID: 16284976

Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, Shyr Y, Murphy BM, Cmelak AJ, Burkey BB, Netterville JL, Levy S, Yarbrough WG, Chung CH: Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res. 2006 Feb 1. PMID: 16467079

Wang J, He X, Luo Y, Yarbrough WG: A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2. Biochem J. 2006 Jan 15. PMID: 16173922

Zanation AM, Yin X, Shores C, Yarbrough WG: Phenotypic and microarray gene expression analysis of tri-dimensional raft-modeled human head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2004 Nov. PMID: 15523429

Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, Butterfoss D, Xiang D, Zanation A, Yin X, Shockley WW, Weissler MC, Dressler LG, Shores CG, Yarbrough WG, Perou CM: Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell. 2004 May. PMID: 15144956

Becker MT, Shores CG, Yu KK, Yarbrough WG: Molecular assay to detect metastatic head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004 Jan. PMID: 14732763

Brinson GM, Senior BA, Yarbrough WG: Endoscopic management of retained airgun projectiles in the paranasal sinuses. Otolaryngol Head Neck Surg. 2004 Jan. PMID: 14726907

Yarbrough WG: The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma. Laryngoscope. 2002 Dec. PMID: 12461329

Yu KK, Zanation AM, Moss JR, Yarbrough WG: Familial head and neck cancer: molecular analysis of a new clinical entity. Laryngoscope. 2002 Sep. PMID: 12352668

Yarbrough WG, Bessho M, Zanation A, Bisi JE, Xiong Y: Human tumor suppressor ARF impedes S-phase progression independent of p53. Cancer Res. 2002 Feb 15. PMID: 11861400

Poole ME, Sailer SL, Rosenman JG, Tepper JE, Weissler MC, Shockley WW, Yarbrough WG, Pillsbury HC 3rd, Schell MJ, Bernard SA: Chemoradiation for locally advanced squamous cell carcinoma of the head and neck for organ preservation and palliation. Arch Otolaryngol Head Neck Surg. 2001 Dec. PMID: 11735812

Ferguson M, Smith TL, Zanation AM, Yarbrough WG: Radiofrequency tissue volume reduction: multilesion vs single-lesion treatments for snoring. Arch Otolaryngol Head Neck Surg. 2001 Sep. PMID: 11556863

Tschan MP, Vonlanthen S, Cajot JF, Peters UR, Oppliger E, Betticher DC, Yarbrough WG, Fey MF, Tobler A: Different p16INK4a and p14ARF expression patterns in acute myeloid leukaemia and normal blood leukocytes. Leuk Lymphoma. 2001 Sep-Oct. PMID: 11697625

Hutchin ME, Pickles RJ, Yarbrough WG: Efficiency of adenovirus-mediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression. Hum Gene Ther. 2000 Nov 20. PMID: 11096441

Hutchin ME, Gilmer C, Yarbrough WG: Delayed-onset sensorineural hearing loss in a 3-year-old survivor of persistent pulmonary hypertension of the newborn. Arch Otolaryngol Head Neck Surg. 2000 Aug. PMID: 10922237

Itoshima T, Fujiwara T, Waku T, Shao J, Kataoka M, Yarbrough WG, Liu TJ, Roth JA, Tanaka N, Kodama M: Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation. Clin Cancer Res. 2000 Jul. PMID: 10914734

Yarbrough WG: RESPONSE: re: biologic and biochemical analyses of p16(INK4a) mutations from primary tumors J Natl Cancer Inst. 2000 May 3. PMID: 10793121

Labadie RF, Yarbrough WG, Weissler MC, Pillsbury HC, Mukherji SK: Nodal volume reduction after concurrent chemo- and radiotherapy: correlation between initial CT and histopathologic findings. AJNR Am J Neuroradiol. 2000 Feb. PMID: 10696014

Hutchin ME, Shores CG, Bauer MS, Yarbrough WG: Sinogenic subdural empyema and Streptococcus anginosus. Arch Otolaryngol Head Neck Surg. 1999 Nov. PMID: 10555700

Yarbrough WG, Buckmire RA, Bessho M, Liu ET: Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors. J Natl Cancer Inst. 1999 Sep 15. PMID: 10491434

Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC: Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Oncogene. 1998 Nov 26. PMID: 9840942

Shores CG, Yarbrough WG: Three-dimensional xenograft model of dysplastic human laryngeal mucosa. Laryngoscope. 1998 Sep. PMID: 9738757

Zhang Y, Xiong Y, Yarbrough WG: ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 1998 Mar 20. PMID: 9529249

Olshan AF, Weissler MC, Pei H, Conway K, Anderson S, Fried DB, Yarbrough WG: Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene. 1997 Feb 20. PMID: 9047388

Yarbrough WG, Aprelikova O, Pei H, Olshan AF, Liu ET: Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele. J Natl Cancer Inst. 1996 Oct 16. PMID: 8841025

McQueen CT, Yarbrough WG, Witsell DL, Holmes DK, Shockley WW: Unilateral supraglottitis in adults: fact or fiction. J Otolaryngol. 1995 Aug. PMID: 8551540

Witsell DL, Garrett CG, Yarbrough WG, Dorrestein SP, Drake AF, Weissler MC: Effect of Lactobacillus acidophilus on antibiotic-associated gastrointestinal morbidity: a prospective randomized trial. J Otolaryngol. 1995 Aug. PMID: 8551535

Witsell DL, Yarbrough WG, Garrett CG, Weissler MC: Treatment of isolated laryngeal blastomycosis with ketoconazole. Photographic documentation of a successful case. N C Med J. 1994 Dec. PMID: 7854464

Yarbrough WG, Shores C, Witsell DL, Weissler MC, Fidler ME, Gilmer TM: ras mutations and expression in head and neck squamous cell carcinomas. Laryngoscope. 1994 Nov. PMID: 7968162

Yarbrough WG, Brownlee RE, Pillsbury HC: Primary anastomosis of extensive facial nerve defects: an anatomic study. Am J Otol. 1993 May. PMID: 8372920

Yarbrough WG, Quarmby VE, Simental JA, Joseph DR, Sar M, Lubahn DB, Olsen KL, French FS, Wilson EM: A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat. J Biol Chem. 1990 May 25. PMID: 2341409

Quarmby VE, Yarbrough WG, Lubahn DB, French FS, Wilson EM: Autologous down-regulation of androgen receptor messenger ribonucleic acid. Mol Endocrinol. 1990 Jan. PMID: 2325667

French FS, Lubahn DB, Brown TR, Simental JA, Quigley CA, Yarbrough WG, Tan JA, Sar M, Joseph DR, Evans BA: Molecular basis of androgen insensitivity. Recent Prog Horm Res. 1990. PMID: 2281183

Wilson EM, Wright BT, Yarbrough WG: The possible role of disulfide bond reduction in transformation of the 10 S androgen receptor. J Biol Chem. 1986 May 15. PMID: 3700403